Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACH24 in Vitiligo
NCT01419964Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ACH24 in Vitiligo, sponsored by Aché Laboratórios Farmacêuticos. Planned start Jan 2012; status: withdrawn.
02
Drugs
ACH24
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT01419964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419964.